Large-Scale Analysis of KIT Aberrations in Chinese Patients with Melanoma

被引:206
作者
Kong, Yan [1 ]
Si, Lu [1 ]
Zhu, Yanyan [1 ]
Xu, Xiaowei [2 ]
Corless, Christopher L. [3 ]
Flaherty, Keith T. [4 ]
Li, Li [1 ]
Li, Haifu [1 ]
Sheng, Xinan [1 ]
Cui, Chuanliang [1 ]
Chi, Zhihong [1 ]
Li, Siming [1 ]
Han, Mei [1 ]
Mao, Lili [1 ]
Lu, Aiping [1 ]
Guo, Jun [1 ]
机构
[1] Peking Univ, Dept Renal Canc & Melanoma, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China
[2] Univ Penn, Dept Pathol & Lab Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[3] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA
[4] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
基金
中国国家自然科学基金;
关键词
GASTROINTESTINAL STROMAL TUMORS; AMERICAN JOINT COMMITTEE; ACUTE MYELOID-LEUKEMIA; PHASE-II TRIAL; C-KIT; IMATINIB MESYLATE; METASTATIC MELANOMA; PROTEIN EXPRESSION; PROGNOSTIC FACTORS; MUTATIONS;
D O I
10.1158/1078-0432.CCR-10-2346
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Purpose: KIT aberrations were described in acral and mucosal melanomas in largely Caucasian populations. Asian populations are more prone to develop acral and mucosal than cutaneous melanomas, and may harbor a high frequency of KIT aberrations. Experimental Design: Melanoma subtypes (n = 502) were analyzed histologically to determine melanoma subtype. Tissue samples were analyzed for mutations in exons 9, 11, 13, 17, and 18 of KIT gene in genomic DNA by PCR amplification and Sanger sequencing. The copy numbers of the KIT gene were analyzed by quantitative PCR, and protein expression levels of KIT (CD117) were determined by immunohistochemistry. Results: The most common melanoma subtypes were acral (38.4%) and mucosal (33.3%) melanomas in this population. The overall incidence of somatic mutations within the KIT gene was 10.8% (54/502), and all subtypes of melanoma contained KIT mutations. Increases in KIT gene copy numbers were correlated to CD117 overexpression. The genetic mutations of KIT were unrelated to the age, gender, stage, thickness, and ulceration of primary melanomas. Importantly, the overall survival of melanoma patients with KIT mutations (P = 0.001) or with KIT aberrations (mutation plus amplification, P = 0.0002) was significantly shorter than that of patients without such alterations. Conclusion: In China, the prevalent melanomas are acral and mucosal melanomas. KIT mutations are detected in all melanoma subtypes. Our study suggests that increases in KIT gene copy numbers, but not KIT mutations, may be correlated to CD117 overexpression. For the first time, our study suggests that genetic KIT aberration is an adverse prognostic factor for melanoma. Clin Cancer Res; 17(7); 1684-91. (C) 2011 AACR.
引用
收藏
页码:1684 / 1691
页数:8
相关论文
共 34 条
[1]
L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition [J].
Antonescu, Cristina R. ;
Busam, Klaus J. ;
Francone, Todd D. ;
Wong, Grace C. ;
Guo, Tianhua ;
Agaram, Narasimhan P. ;
Besmer, Peter ;
Jungbluth, Achim ;
Gimbel, Mark ;
Chen, Chin-Tung ;
Veach, Darren ;
Clarkson, Bayard D. ;
Paty, Philip B. ;
Weiser, Martin R. .
INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (02) :257-264
[2]
Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas [J].
Ashida, Atsuko ;
Takata, Minoru ;
Murata, Hiroshi ;
Kido, Kenji ;
Saida, Toshiaki .
INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (04) :862-868
[3]
The biology of stem cell factor and its receptor C-kit [J].
Ashman, LK .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1999, 31 (10) :1037-1051
[4]
Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system [J].
Balch, CM ;
Soong, SJ ;
Gershenwald, JE ;
Thompson, JF ;
Reintgen, DS ;
Cascinelli, N ;
Urist, M ;
McMasters, KM ;
Ross, MI ;
Kirkwood, JM ;
Atkins, MB ;
Thompson, JA ;
Coit, DG ;
Byrd, D ;
Desmond, R ;
Zhang, YT ;
Liu, PY ;
Lyman, GH ;
Morabito, A .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3622-3634
[5]
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma [J].
Balch, CM ;
Buzaid, AC ;
Soong, SJ ;
Atkins, MB ;
Cascinelli, N ;
Coit, DG ;
Fleming, ID ;
Gershenwald, JE ;
Houghton, A ;
Kirkwood, JM ;
McMasters, KM ;
Mihm, MF ;
Morton, DL ;
Reintgen, DS ;
Ross, MI ;
Sober, A ;
Thompson, JA ;
Thompson, JF .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3635-3648
[6]
KIT Gene Mutations and Copy Number in Melanoma Subtypes [J].
Beadling, Carol ;
Jacobson-Dunlop, Erick ;
Hodi, F. Stephen ;
Le, Claudia ;
Warrick, Andrea ;
Patterson, Janice ;
Town, Ajia ;
Harlow, Amy ;
Cruz, Frank, III ;
Azar, Sharl ;
Rubin, Brian P. ;
Muller, Susan ;
West, Rob ;
Heinrich, Michael C. ;
Corless, Christopher L. .
CLINICAL CANCER RESEARCH, 2008, 14 (21) :6821-6828
[7]
Byrd-Miles Katina, 2007, J Drugs Dermatol, V6, P10
[8]
Carvajal RD, 2009, J CLIN ONCOL S, V27
[9]
Autoinhibition of the Kit receptor tyrosine kinase by the cytosolic juxtamembrane region [J].
Chang, PM ;
Ilangumaran, S ;
La Rose, J ;
Chakrabartty, A ;
Rottapel, R .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (09) :3067-3078
[10]
Distinct sets of genetic alterations in melanoma [J].
Curtin, JA ;
Fridlyand, J ;
Kageshita, T ;
Patel, HN ;
Busam, KJ ;
Kutzner, H ;
Cho, KH ;
Aiba, S ;
Bröcker, EB ;
LeBoit, PE ;
Pinkel, D ;
Bastian, BC .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2135-2147